Drug Approval | July 31, 2022
Casper Pharma completed USFDA pre-approval inspection
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
With this, the company can start selling Ibuprofen in the European markets.
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
Company is investing more than €100 million in the expansion of the Halle site
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Addition of Pepscan with its peptide discovery, lead optimization and GMP manufacturing capabilities provides end-to-end offering to Biosynth Carbosynth’s peptide customers.
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
Bringing next-gen cannabinoid therapeutics to cancer patients
Subscribe To Our Newsletter & Stay Updated
